These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28639487)

  • 1. MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy.
    Vos K; Sciuto CL; Piedade R; Ashton M; Björkman A; Ngasala B; Mårtensson A; Gil JP
    Pharmacogenomics; 2017 Jul; 18(10):981-985. PubMed ID: 28639487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
    Ashley EA; Stepniewska K; Lindegårdh N; McGready R; Annerberg A; Hutagalung R; Singtoroj T; Hla G; Brockman A; Proux S; Wilahphaingern J; Singhasivanon P; White NJ; Nosten F
    Trop Med Int Health; 2007 Feb; 12(2):201-8. PubMed ID: 17300626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda.
    Checchi F; Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor WR; Guthmann JP
    Malar J; 2006 Jul; 5():59. PubMed ID: 16854236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
    Wernsdorfer WH
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the pharmacokinetics of Coartem.
    Djimdé A; Lefèvre G
    Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S4. PubMed ID: 19818171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger.
    Denoeud-Ndam L; Dicko A; Baudin E; Guindo O; Grandesso F; Diawara H; Sissoko S; Sanogo K; Traoré S; Keita S; Barry A; de Smet M; Lasry E; Smit M; Wiesner L; Barnes KI; Djimde AA; Guerin PJ; Grais RF; Doumbo OK; Etard JF
    BMC Med; 2016 Oct; 14(1):167. PubMed ID: 27776521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria.
    Borrmann S; Sallas WM; Machevo S; González R; Björkman A; Mårtensson A; Hamel M; Juma E; Peshu J; Ogutu B; Djimdé A; D'Alessandro U; Marrast AC; Lefèvre G; Kern SE
    Trop Med Int Health; 2010 Apr; 15(4):434-41. PubMed ID: 20180933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study.
    Lefèvre G; Bhad P; Jain JP; Kalluri S; Cheng Y; Dave H; Stein DS
    Malar J; 2013 Sep; 12():312. PubMed ID: 24010572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy.
    Parikh S; Fehintola F; Huang L; Olson A; Adedeji WA; Darin KM; Morse GD; Murphy RL; Taiwo BO; Akinyinka OO; Adewole IF; Aweeka FT; Scarsi KK
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7852-6. PubMed ID: 26392500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms.
    Malmberg M; Ferreira PE; Tarning J; Ursing J; Ngasala B; Björkman A; Mårtensson A; Gil JP
    J Infect Dis; 2013 Mar; 207(5):842-7. PubMed ID: 23225895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
    McGready R; Stepniewska K; Lindegardh N; Ashley EA; La Y; Singhasivanon P; White NJ; Nosten F
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1021-31. PubMed ID: 17053895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.
    Mosha D; Guidi M; Mwingira F; Abdulla S; Mercier T; Decosterd LA; Csajka C; Genton B
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4583-92. PubMed ID: 24867986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.
    Parikh S; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Gao Q; Li F; Were M; Kakuru A; Achan J; Mwebaza N; Aweeka FT
    Clin Infect Dis; 2016 Aug; 63(3):414-22. PubMed ID: 27143666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.
    Mutagonda RF; Kamuhabwa AAR; Minzi OMS; Massawe SN; Asghar M; Homann MV; Färnert A; Aklillu E
    Malar J; 2017 Jul; 16(1):267. PubMed ID: 28673292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.
    Salman S; Page-Sharp M; Griffin S; Kose K; Siba PM; Ilett KF; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5306-13. PubMed ID: 21876056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.
    Lefèvre G; Carpenter P; Souppart C; Schmidli H; McClean M; Stypinski D
    Br J Clin Pharmacol; 2002 Nov; 54(5):485-92. PubMed ID: 12445027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda.
    Fogg C; Bajunirwe F; Piola P; Biraro S; Checchi F; Kiguli J; Namiiro P; Musabe J; Kyomugisha A; Guthmann JP
    Am J Trop Med Hyg; 2004 Nov; 71(5):525-30. PubMed ID: 15569777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oil-Fortified Maize Porridge Increases Absorption of Lumefantrine in Children with Uncomplicated Falciparum Malaria.
    Mwebaza N; Jerling M; Gustafsson LL; Silva AV; Pohanka A; Obua C; Waako P; Beck O; Homann MV; Färnert A; Hellgren U
    Basic Clin Pharmacol Toxicol; 2017 May; 120(5):457-465. PubMed ID: 27883269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects.
    Lefèvre G; Carpenter P; Souppart C; Schmidli H; Martin JM; Lane A; Ward C; Amakye D
    J Clin Pharmacol; 2002 Oct; 42(10):1147-58. PubMed ID: 12362930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.